News from Tarsa Therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

13 Aug, 2014, 07:00 ET Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director

 Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank....


12 Oct, 2012, 08:00 ET Tarsa Therapeutics To Assist Therapicon In Its Challenge To CHMP's Recommendation To Limit Use Of Calcitonin

 Tarsa Therapeutics today announced an agreement in principle with Therapicon® Slr to provide consulting assistance to the Italian firm in...


21 Mar, 2012, 07:30 ET Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma

Tarsa Therapeutics today announced it has entered into a commercial supply agreement with QS Pharma for the bulk manufacture of its OSTORA™...


13 Dec, 2011, 08:00 ET Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin

Tarsa Therapeutics today confirmed that it is planning to submit a New Drug Application (NDA) to the Food and Drug Administration (FDA) in the...


19 Sep, 2011, 07:00 ET Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial

Tarsa Therapeutics today reported that it presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA™, the...


12 Jul, 2011, 07:30 ET Tarsa Therapeutics Advances Its Oral Calcitonin for the Treatment and Prevention of Postmenopausal Osteoporosis

Tarsa Therapeutics today reported progress in its two ongoing  clinical development programs for its oral recombinant salmon calcitonin for...